Allspring Global Investments’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Allspring Global Investments's ELV Position: Q2 2026 in Review
Allspring Global Investments increased its Elevance Health (ELV) stake by 1% in Q2 2026, buying an estimated $39.3K and bringing the position to 10,212 shares worth $4.25M. The position accounts for 0.01% of the portfolio, ranked #919.
Allspring Global Investments first reported a position in ELV in Q4 2021 and has held it in 19 quarters since. The position peaked at $87.3M in Q4 2022. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Allspring Global Investments held 10,212 shares of Elevance Health worth $4.25M as of Q2 2026.
- Allspring Global Investments bought 106 Elevance Health shares in Q2 2026, an estimated $39.3K.
- Elevance Health made up 0.01% of Allspring Global Investments's portfolio in Q2 2026, its #919 holding.
- Allspring Global Investments first reported a position in Elevance Health in Q4 2021 and has held it in 19 quarters since.
- Allspring Global Investments's Elevance Health position peaked at $87.3M in Q4 2022.
- 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.